5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Brain Representation of Animal and Non-Animal Images in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          In early Alzheimer’s disease (AD), high-level visual functions and processing speed are impacted. Few functional magnetic resonance imaging (fMRI) studies have investigated high-level visual deficits in AD, yet none have explored brain activity patterns during rapid animal/non-animal categorization tasks.

          Objective:

          To address this, we utilized the previously known Integrated Cognitive Assessment (ICA) to collect fMRI data and compare healthy controls (HC) to individuals with mild cognitive impairment (MCI) and mild AD.

          Methods:

          The ICA encompasses a rapid visual categorization task that involves distinguishing between animals and non-animals within natural scenes. To comprehensively explore variations in brain activity levels and patterns, we conducted both univariate and multivariate analyses of fMRI data.

          Results:

          The ICA task elicited activation across a range of brain regions, encompassing the temporal, parietal, occipital, and frontal lobes. Univariate analysis, which compared responses to animal versus non-animal stimuli, showed no significant differences in the regions of interest (ROIs) across all groups, with the exception of the left anterior supramarginal gyrus in the HC group. In contrast, multivariate analysis revealed that in both HC and MCI groups, several regions could differentiate between animals and non-animals based on distinct patterns of activity. Notably, such differentiation was absent within the mild AD group.

          Conclusions:

          Our study highlights the ICA task’s potential as a valuable cognitive assessment tool designed for MCI and AD. Additionally, our use of fMRI pattern analysis provides valuable insights into the complex changes in brain function associated with AD. This approach holds promise for enhancing our understanding of the disease’s progression.

          Related collections

          Most cited references73

          • Record: found
          • Abstract: found
          • Article: not found

          The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

          To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. Validation study. A community clinic and an academic center. Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score > or =17), and 90 healthy elderly controls (NC). The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD. Using a cutoff score 26, the MMSE had a sensitivity of 18% to detect MCI, whereas the MoCA detected 90% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78%, whereas the MoCA detected 100%. Specificity was excellent for both MMSE and MoCA (100% and 87%, respectively). MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

              The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia. Copyright © 2011. Published by Elsevier Inc.
                Bookmark

                Author and article information

                Journal
                J Alzheimers Dis Rep
                J Alzheimers Dis Rep
                ADR
                Journal of Alzheimer's Disease Reports
                IOS Press (Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands )
                2542-4823
                20 October 2023
                2023
                : 7
                : 1
                : 1133-1152
                Affiliations
                [a ]School of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM) , Tehran, Iran
                [b ]Western University , London, Ontario, Canada
                [c ]Department of Geriatric Medicine, Ziaeian Hospital, Tehran University of Medical Sciences , Tehran, Iran
                [d ]Memory and Behavioral Neurology Division, Roozbeh Hospital, Tehran University of Medical Sciences , Tehran, Iran
                [e ]Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology , ACECR, Tehran, Iran
                [f ]Department of Psychology and Neuroscience, Boston College , Boston, MA, USA
                [g ]School of Electrical and Computer Engineering, University of Tehran , Tehran, Iran
                [h ]South London & Maudsley NHS Foundation Trust, London, United Kingdom
                [i ]Department of Old Age Psychiatry, King’s College London , London, United Kingdom
                [j ]Cognetivity Ltd, London, United Kingdom
                Author notes
                [* ]Correspondence to: Haniyeh Marefat, School of Cognitive Sciences, IPM Opposite the ARAJ, Artesh Highway, Aghdassieh, 1956836484, Tehran, Iran. Tel.: +98 912 3512967; E-mails: haniyemarefat@ 123456ipm.ir , haniyemarefat94@ 123456gmail.com and Khaligh-Razavi Seyed-Mahdi, 3 Waterhouse Sq, London, UK. Tel.: +44 07754369938; E-mail: seyed@ 123456cognetivity.com .
                Article
                ADR230132
                10.3233/ADR-230132
                10657719
                cf2bc4f3-c6dc-4d56-a023-a8d5f16b9b3e
                © 2023 – The authors. Published by IOS Press

                This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 February 2023
                : 6 September 2023
                Categories
                Research Report

                alzheimer’s disease,high-level visual categorization,functional mri,mild cognitive impairment,multivariate pattern analysis

                Comments

                Comment on this article